People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| H1 Insights, Inc. | — | Other | Series D+ | $271.0M | $844.6M | 2020 |
| Illumigyn Ltd. | — | Biotechnology | Seed | $2.0M | $88.8M | 2016 |
Ariel Katz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ariel Katz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Somesh Dash | 1 | 8 |
| Greg Yap | 1 | 8 |
| Richard Stone | 1 | 6 |
| Moshe Moalem | 1 | 3 |
| Morry Blumenfeld | 1 | 2 |
| Deborah Schwartz | 1 | 2 |
| Karen Walker | 1 | 2 |
| Lior Greenstein | 1 | 1 |
| Ian Sax | 1 | 1 |
| Mike Derezin | 1 | 1 |
| Micah Brooks | 1 | 1 |
| Sylvie Veilleux | 1 | 1 |
| Jacob Bortman | 1 | 1 |
| Gadi Ganon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.